The ESC Guidelines on heart failure, sacubitril-valsartan in resistant hypertension, and new therapeutic targets in myocardial hypertrophy

Filippo Crea

doi:10.1093/eurheartj/ehab627

The ESC Guidelines on heart failure, sacubitril-valsartan in resistant hypertension, and new therapeutic targets in myocardial hypertrophy

Filippo Crea

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

N/A

Lingua originale	Inglese
pagine (da-a)	3581-3585
Numero di pagine	5
Rivista	European Heart Journal
Volume	42
DOI	https://doi.org/10.1093/eurheartj/ehab627
Stato di pubblicazione	Pubblicato - 2021

Keywords

Aminobutyrates
Angiotensin Receptor Antagonists
Biphenyl Compounds
Drug Combinations
Heart Failure
Humans
Hypertension
Hypertrophy
Neprilysin
Stroke Volume
Tetrazoles
Valsartan

Accesso al documento

10.1093/eurheartj/ehab627

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{b6cb509f5b384ee68aef4d58c3c4762b,

title = "The ESC Guidelines on heart failure, sacubitril-valsartan in resistant hypertension, and new therapeutic targets in myocardial hypertrophy",

abstract = "N/A",

keywords = "Aminobutyrates, Angiotensin Receptor Antagonists, Biphenyl Compounds, Drug Combinations, Heart Failure, Humans, Hypertension, Hypertrophy, Neprilysin, Stroke Volume, Tetrazoles, Valsartan, Aminobutyrates, Angiotensin Receptor Antagonists, Biphenyl Compounds, Drug Combinations, Heart Failure, Humans, Hypertension, Hypertrophy, Neprilysin, Stroke Volume, Tetrazoles, Valsartan",

author = "Filippo Crea",

year = "2021",

doi = "10.1093/eurheartj/ehab627",

language = "English",

volume = "42",

pages = "3581--3585",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - The ESC Guidelines on heart failure, sacubitril-valsartan in resistant hypertension, and new therapeutic targets in myocardial hypertrophy

AU - Crea, Filippo

PY - 2021

Y1 - 2021

N2 - N/A

AB - N/A

KW - Aminobutyrates

KW - Angiotensin Receptor Antagonists

KW - Biphenyl Compounds

KW - Drug Combinations

KW - Heart Failure

KW - Humans

KW - Hypertension

KW - Hypertrophy

KW - Neprilysin

KW - Stroke Volume

KW - Tetrazoles

KW - Valsartan

KW - Aminobutyrates

KW - Angiotensin Receptor Antagonists

KW - Biphenyl Compounds

KW - Drug Combinations

KW - Heart Failure

KW - Humans

KW - Hypertension

KW - Hypertrophy

KW - Neprilysin

KW - Stroke Volume

KW - Tetrazoles

KW - Valsartan

UR - http://hdl.handle.net/10807/204542

U2 - 10.1093/eurheartj/ehab627

DO - 10.1093/eurheartj/ehab627

M3 - Article

SN - 0195-668X

VL - 42

SP - 3581

EP - 3585

JO - European Heart Journal

JF - European Heart Journal

ER -

The ESC Guidelines on heart failure, sacubitril-valsartan in resistant hypertension, and new therapeutic targets in myocardial hypertrophy

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo